- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Sanofi Consumer Healthcare India Limited's board has approved strong financial results. Quarterly revenue from operations grew 28% year-over-year to ₹220.9 Cr. Net profit for the quarter soared 109% year-over-year to ₹60.7 Cr, showing a 21% sequential increase. The company benefited from a ₹6.6 Cr exceptional gain by reversing demerger provisions. Operationally, Depura Adult and Combiflam Suspension were relaunched post-recalls. Notably, Opal JVco S.a.r.l is now the ultimate parent following a global stake sale by Sanofi.
All announcements from Sanofi Consumer Healthcare India Limited